$9,915.88 consulting Payment -- Bayer Healthcare to Dr. Mark Perez

Hematologist Receives $9,915.88 Consulting Fee from Bayer Healthcare for Xarelto

This page provides a detailed analysis of a $9,915.88 consulting payment from Bayer Healthcare to Dr. Mark Perez. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$9,915.88
Payment Typeconsulting
Payment NatureConsulting Fee
Pharmaceutical CompanyBayer Healthcare
PhysicianDr. Mark Perez
NPI Number1205829241
Physician SpecialtyHematology
LocationCity, MD
Date of Payment2025-03-27
Related Drug/DeviceXarelto
Conflict AssessmentModerate -- Worth Noting

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Bayer Healthcare made a $9.9K consulting payment to Mark Perez, a Hematology specialist in City, MD. The payment was associated with Xarelto. The payment of $9,915.88 to Dr. Mark Perez from Bayer Healthcare for consulting services related to Xarelto is a significant amount for a single consulting engagement. This payment falls under 'Consulting Fee' and is specifically for 'consulting' services, indicating a direct engagement for expertise. The payment was made on March 27, 2025, suggesting a recent or future engagement with the pharmaceutical company.

Patient Guidance: What This Payment Means for You

If you are a patient prescribed Xarelto, understand that your doctor may receive consulting fees from the manufacturer for their expertise. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

For a Hematologist, a consulting fee of nearly $10,000 for services related to a specific drug like Xarelto is a moderate payment, depending on the scope and duration of the consulting.

Regulatory Context: Sunshine Act Requirements

This payment is subject to reporting under the Sunshine Act, requiring disclosure of financial relationships between drug manufacturers and healthcare providers.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding consulting Payments

Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.

Frequently Asked Questions About This Payment

What was this $9.9K payment for?

This was a consulting payment of $9.9K from Bayer Healthcare to Mark Perez, categorized as "Consulting Fee". It was associated with Xarelto. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Mark Perez accept pharmaceutical money?

Yes, Mark Perez received this $9.9K payment from Bayer Healthcare. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Mark Perez's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this consulting payment?

A consulting payment of $9.9K may reflect legitimate advisory services the physician provides. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Hematology?

To compare this payment against Hematology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Hematology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Mark Perez's relationship with Bayer Healthcare?

The payment amount is substantial for a consulting fee. This $9.9K consulting payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Hematology?

The payment is specifically for consulting services, not for speaking, meals, or other common categories.

What should patients do after learning about this payment?

If you are a patient prescribed Xarelto, understand that your doctor may receive consulting fees from the manufacturer for their expertise.

What else should I know about this consulting payment?

Dr. Perez's specialty is Hematology, which aligns with the drug Xarelto, an anticoagulant.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.